These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. [Study of the systematics of insulin action using the example of glycogen storage disease]. DOST FH Arztl Forsch; 1948 Dec; 2(24):465-71. PubMed ID: 18116144 [No Abstract] [Full Text] [Related]
65. Effect of Safarzad M; Marjani A; Saghaeian Jazi M; Qujeq D; Mir SM; Marjani M; Nezhadebrahimi Kaldehi A Diabetes Metab Syndr Obes; 2020; 13():1109-1116. PubMed ID: 32341660 [TBL] [Abstract][Full Text] [Related]
66. Sorting Out the Receptor Isoforms Underlying Dopamine Inhibition of Insulin Secretion. Kebede MA; Piston DW Diabetes; 2022 Sep; 71(9):1831-1833. PubMed ID: 35984964 [No Abstract] [Full Text] [Related]
67. Glycogen secretion in the epididymis. NICANDER L Nature; 1954 Oct; 174(4432):700-1. PubMed ID: 13213988 [No Abstract] [Full Text] [Related]
68. The distribution of histochemically demonstrable glycogen in human blood and bone marrow cells. WACHSTEIN M Blood; 1949 Jan; 4(1):54-9. PubMed ID: 18103215 [No Abstract] [Full Text] [Related]
69. [On the question of glyconeogeny in the organism]. STOHR R Wien Klin Wochenschr; 1948 Aug; 60(33):540. PubMed ID: 18934381 [No Abstract] [Full Text] [Related]
70. Could micro changes in β-cells enable major changes in metabolism? Capozzi ME; Campbell JE EBioMedicine; 2020 Sep; 59():102936. PubMed ID: 32810821 [No Abstract] [Full Text] [Related]
71. Diabetes induces remodeling of the left atrial appendage independently of atrial fibrillation in a rodent model of type-2 diabetes. Yosefy O; Sharon B; Yagil C; Shlapoberski M; Livoff A; Novitski I; Beeri R; Yagil Y; Yosefy C Cardiovasc Diabetol; 2021 Jul; 20(1):149. PubMed ID: 34301258 [TBL] [Abstract][Full Text] [Related]
72. Effects of Polyphenols on Insulin Resistance. Williamson G; Sheedy K Nutrients; 2020 Oct; 12(10):. PubMed ID: 33066504 [TBL] [Abstract][Full Text] [Related]
73. Upregulation of UCP2 in beta-cells confers partial protection against both oxidative stress and glucotoxicity. Li N; Karaca M; Maechler P Redox Biol; 2017 Oct; 13():541-549. PubMed ID: 28755631 [TBL] [Abstract][Full Text] [Related]
74. Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells? Ashcroft FM; Rohm M; Clark A; Brereton MF Cell Metab; 2017 Jul; 26(1):17-23. PubMed ID: 28683284 [TBL] [Abstract][Full Text] [Related]
75. Mechanisms of the amplifying pathway of insulin secretion in the β cell. Kalwat MA; Cobb MH Pharmacol Ther; 2017 Nov; 179():17-30. PubMed ID: 28527919 [TBL] [Abstract][Full Text] [Related]
76. Glycogen metabolism in the glucose-sensing and supply-driven β-cell. Andersson LE; Nicholas LM; Filipsson K; Sun J; Medina A; Al-Majdoub M; Fex M; Mulder H; Spégel P FEBS Lett; 2016 Dec; 590(23):4242-4251. PubMed ID: 27943300 [TBL] [Abstract][Full Text] [Related]
77. Genetic models rule out a major role of beta cell glycogen in the control of glucose homeostasis. Mir-Coll J; Duran J; Slebe F; García-Rocha M; Gomis R; Gasa R; Guinovart JJ Diabetologia; 2016 May; 59(5):1012-20. PubMed ID: 26825527 [TBL] [Abstract][Full Text] [Related]
78. cAMP-mediated and metabolic amplification of insulin secretion are distinct pathways sharing independence of β-cell microfilaments. Mourad NI; Nenquin M; Henquin JC Endocrinology; 2012 Oct; 153(10):4644-54. PubMed ID: 22948217 [TBL] [Abstract][Full Text] [Related]
79. Transcripts of calcium/calmodulin-dependent kinases are changed after forskolin- or IBMX-induced insulin secretion due to melatonin treatment of rat insulinoma beta-cells (INS-1). Bazwinsky-Wutschke I; Mühlbauer E; Wolgast S; Peschke E Horm Metab Res; 2009 Nov; 41(11):805-13. PubMed ID: 19598075 [TBL] [Abstract][Full Text] [Related]